Nahad Sedaghat Selected Research

BIBP COVID-19 vaccine

12/2022	Self-Reported safety of the BBIBP-CorV (Sinopharm) COVID-19 vaccine among Iranian people with multiple sclerosis.
12/2022	Detection of anti-NMDA receptor antibodies following BBIBP-CorV COVID-19 vaccination in a rituximab-treated person with multiple sclerosis presenting with manifestations of an acute relapse.
1/2022	SARS-CoV-2 serology among people with multiple sclerosis on disease-modifying therapies after BBIBP-CorV (Sinopharm) inactivated virus vaccination: Same story, different vaccine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nahad Sedaghat Research Topics

Disease

6	Multiple Sclerosis 12/2022 - 01/2021
6	COVID-19 12/2022 - 01/2021
2	Myalgia 12/2022 - 10/2021
1	Autoimmune Diseases of the Nervous System 12/2022
1	Encephalitis (Encephalitis, Rasmussen) 12/2022
1	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 12/2022
1	Ulcerative Colitis 12/2022
1	Demyelinating Diseases (Demyelinating Disease) 01/2022
1	Hemorrhage 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 10/2021
1	Fatigue 10/2021
1	Infections 01/2021

Drug/Important Bio-Agent (IBA)

4	VaccinesIBA 12/2022 - 10/2021
3	COVID-19 VaccinesIBA 12/2022 - 10/2021
3	BIBP COVID-19 vaccineIBA 12/2022 - 01/2022
2	Rituximab (Mabthera)FDA Link 12/2022 - 10/2021
1	AntibodiesIBA 12/2022
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2022
1	Natalizumab (Tysabri)FDA Link 12/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2022
1	Tranexamic Acid (AMCA)FDA Link 01/2022
1	Chimeric Antigen ReceptorsIBA 01/2022
1	SteroidsIBA 10/2021
1	Pharmaceutical PreparationsIBA 01/2021

Therapy/Procedure

3	Therapeutics 01/2022 - 01/2021
1	Rhinoplasty 01/2022